Clinical Trial Finder

Many patients with angina are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China

Condition:   Acute Coronary Syndrome
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Recruiting - verified April 2017

Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry

Conditions:   Stable Angina;   Unstable Angina;   ACS - Acute Coronary Syndrome;   STEMI;   NSTEMI - Non-ST Segment Elevation MI;   Myocardial Infarction
Intervention:   Device: COBRA PzF Coronary Stent System
Sponsors:   CeloNova BioSciences, Inc.;   Alpin ARC
Active, not recruiting - verified April 2017

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs

Condition:   Coronary Artery Disease
Intervention:   Other: home-based cardiac rehabilitation
Sponsor:   Chinese PLA General Hospital
Not yet recruiting - verified April 2017

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Conditions:   Type2 Diabetes;   Dyslipidemia
Interventions:   Drug: K-877;   Drug: Placebo
Sponsors:   Kowa Research Institute, Inc.;   Brigham and Women's Hospital
Recruiting - verified April 2017

Comparing TR Band to Statseal in Conjunction With TR Band

Conditions:   Arterial Occlusion;   Angina Pectoris;   Cardiovascular Diseases;   Atherosclerosis;   Hematoma;   Anticoagulant-Induced Bleeding;   Coronary Artery Disease
Interventions:   Device: StatSeal;   Device: TR Band
Sponsor:   VA Long Beach Healthcare System
Recruiting - verified April 2017

Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease

Condition:   Coronary Artery Disease
Sponsors:   Bassett Healthcare;   Baylor University
Recruiting - verified April 2017

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: semaglutide;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Recruiting - verified April 2017

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Condition:   Prostate Cancer
Interventions:   Drug: Degarelix;   Drug: Leuprolide
Sponsors:   Ferring Pharmaceuticals;   Memorial Sloan Kettering Cancer Center;   Duke Clinical Research Institute
Recruiting - verified April 2017

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus

Conditions:   Coronary Artery Disease;   Diabetes Mellitus
Interventions:   Device: Absorb GT1;   Device: Promus
Sponsors:   University of Luebeck;   University of Schleswig-Holstein, Campus Kiel, Germany;   Kerckhoff Klinik;   Charite University, Berlin, Germany
Terminated - verified April 2017

Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting

Conditions:   Coronary Artery Disease;   Myocardial Ischemia;   Myocardial Infarction;   Stent Thrombosis;   Cardiovascular Diseases
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Action Research Group
Recruiting - verified April 2017

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified April 2017

Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases

Condition:   Stable Angina
Intervention:   Procedure: coronary angiography
Sponsor:   Taipei City Hospital
Completed - verified April 2017

Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques

Condition:   Stable Angina
Sponsor:   Taipei City Hospital
Recruiting - verified April 2017

Very Early veRsus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes

Condition:   Coronary Artery Disease
Interventions:   Procedure: Invasive coronary evaluation (Deferred);   Procedure: Invasive coronary evaluation (Acute)
Sponsors:   Rigshospitalet, Denmark;   University Hospital, Gentofte, Copenhagen
Active, not recruiting - verified April 2017

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified January 6, 2017

CArdiac cT in the Treatment of Acute CHest Pain 2 - Myocardial CT Perfusion

Condition:   Coronary Artery Disease
Interventions:   Procedure: CTA+CTP guided treatment strategy;   Procedure: CTA guided treatment strategy
Sponsors:   Rigshospitalet, Denmark;   Copenhagen University Hospital, Hvidovre;   Amager Hospital;   Bispebjerg Hospital;   Herlev Hospital;   Glostrup University Hospital, Copenhagen;   University Hospital, Gentofte, Copenhagen
Active, not recruiting - verified April 2017

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Angina Pectoris, Unstable;   Angina Pectoris, Stable;   Thoracic Diseases
Intervention:   Device: heart type fatty acid binding protein testing
Sponsors:   Maastricht University Medical Center;   FABPulous B.V.
Completed - verified April 2017

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: linagliptin;   Drug: glimepiride;   Drug: linagliptin placebo;   Drug: glimepride placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Active, not recruiting - verified April 2017

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Conditions:   Atherosclerosis;   Hypercholesterolemia
Interventions:   Drug: Statin Drugs;   Other: HMG-CoA Reductase Inhibitors
Sponsor:   National Institutes of Health Clinical Center (CC)
Completed - verified February 22, 2017

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

Condition:   Stable Angina
Interventions:   Drug: Intravenous Glycoprotein inhibitor + ASA, Clopidogrel;   Drug: Antiplatelet Therapy (ASA, Clopidogrel)
Sponsor:   Icahn School of Medicine at Mount Sinai
Completed - verified April 2017